Literature DB >> 8150351

Desmoid tumours in familial adenomatous polyposis.

A K Gurbuz1, F M Giardiello, G M Petersen, A J Krush, G J Offerhaus, S V Booker, M C Kerr, S R Hamilton.   

Abstract

Desmoids are rare, benign fibromatous lesions, which can arise in patients with familial adenomatous polyposis (FAP), a disorder caused by germline adenomatous polyposis coli (APC) gene mutation. This study investigated the risk of desmoids in FAP, the relation between specific APC gene mutations and desmoid formation, and the clinical characteristics of FAP patients with desmoids. Eighty three of 825 FAP patients (10%) from 49 of 161 kindreds (30%) had desmoids. The absolute risk of desmoids in FAP patients was 2.56/1000 person years; comparative risk was 852 times the general population. APC gene mutations were similar in families with and without desmoids. The female/male ratio was 1.4 (p = NS). Previous abdominal surgery was noted in 68% of patients with abdominal desmoids (55% developed within five years postoperatively). Desmoid risk in FAP family members of a desmoid patient was 25% in first degree relatives v 8% in third degree relatives. Desmoids are a comparatively common complication of FAP associated with surgical trauma and familial aggregation. Desmoid development was not linked to specific APC gene mutations and was not found predominantly in women. Studies of chemopreventive therapy, given within five years after abdominal surgery, should be considered in FAP patients with a family history of desmoid disease.

Entities:  

Mesh:

Year:  1994        PMID: 8150351      PMCID: PMC1374594          DOI: 10.1136/gut.35.3.377

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Treatment of intra-abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3',5'-adenosine monophosphate.

Authors:  W R Waddell
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

2.  Gardner's syndrome complicated by mesenteric desmoid tumors.

Authors:  J C Harvey; S H Quan; J G Fortner
Journal:  Surgery       Date:  1979-04       Impact factor: 3.982

3.  Extracolonic lesions associated with polyposis coli.

Authors:  H J Bussey
Journal:  Proc R Soc Med       Date:  1972-03

4.  The occurrence of desmoids in patients with familial polyposis coli.

Authors:  W A McAdam; J C Goligher
Journal:  Br J Surg       Date:  1970-08       Impact factor: 6.939

5.  Mesenteric fibromatosis in Gardner's syndrome.

Authors:  C P Karakousis; R A Berjian; R Lopez; U Rao
Journal:  Arch Surg       Date:  1978-08

6.  Gardner's syndrome; review of the literature and report on a family.

Authors:  E L Jones; W P Cornell
Journal:  Arch Surg       Date:  1966-02

7.  Remission of rapidly growing desmoid tumors after tamoxifen therapy.

Authors:  B Kinzbrunner; S Ritter; J Domingo; C J Rosenthal
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

8.  The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.

Authors:  J J Reitamo; T M Scheinin; P Häyry
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

9.  Indomethacin and ascorbate inhibit desmoid tumors.

Authors:  W R Waddell; R E Gerner
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

10.  Spontaneous mesenteric fibromatosis in Gardner's syndrome.

Authors:  R C Richards; S W Rogers; E J Gardner
Journal:  Cancer       Date:  1981-02-01       Impact factor: 6.860

View more
  67 in total

1.  A rare case of desmoid tumor of thigh.

Authors:  Anupam Tiwari; Margaret Topno; Tanweer Karim; Vinod Sharma
Journal:  Indian J Surg       Date:  2010-11-23       Impact factor: 0.656

2.  Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

Authors:  B A Alman; C Li; M E Pajerski; S Diaz-Cano; H J Wolfe
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.

Authors:  Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

4.  Port site desmoid tumour following laparoscopic cholecystectomy: A case report.

Authors:  Gautham Krishnamurthy; Vijay Chetan Jha; Ganga Ram Verma
Journal:  J Minim Access Surg       Date:  2018 Jul-Sep       Impact factor: 1.407

5.  Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature.

Authors:  Christopher J Schmoyer; Harmar D Brereton; Eric W Blomain
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

6.  Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

7.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

9.  Colonic adenomatous polyposis syndromes: clinical management.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2008-11

10.  Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.

Authors:  K Heinimann; B Müllhaupt; W Weber; M Attenhofer; R J Scott; M Fried; S Martinoli; H Müller; Z Dobbie
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.